A novel melanocortin fusion protein inhibits fibrinogen oxidation and degradation during trauma-induced coagulopathy

2.

Battle

CE

,

Hutchings

H

,

Evans

PA

.

Risk factors that predict mortality in patients with blunt chest wall trauma: a systematic review and meta-analysis

.

Injury

.

2012

. ;

43

(

1

):

8

-

17

.

3.

Holcomb

JB

,

Tilley

BC

,

Baraniuk

S

, et al.

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial

.

JAMA

.

2015

. ;

313

(

5

):

471

-

482

.

4.

Holcomb

JB

,

del Junco

DJ

,

Fox

EE

, et al.

The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks

.

JAMA Surg

.

2013

. ;

148

(

2

):

127

-

136

.

5.

Brohi

K

,

Singh

J

,

Heron

M

,

Coats

T

.

Acute traumatic coagulopathy

.

J Trauma

.

2003

. ;

54

(

6

):

1127

-

1130

.

6.

Xiao

W

,

Mindrinos

MN

,

Seok

J

, et al.

A genomic storm in critically injured humans

.

J Exp Med

.

2011

. ;

208

(

13

):

2581

-

2590

.

7.

Johansson

PI

,

Sørensen

AM

,

Perner

A

, et al.

Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? an observational study

.

Crit Care

.

2011

. ;

15

(

6

):

R272(1

-

10)

.

8.

Hess

JR

,

Brohi

K

,

Dutton

RP

, et al.

The coagulopathy of trauma: a review of mechanisms

.

J Trauma

.

2008

. ;

65

(

4

):

748

-

754

.

9.

Savage

SA

,

Zarzaur

BL

,

Gaski

GE

, et al.

Insights into the association between coagulopathy and inflammation: abnormal clot mechanics are a warning of immunologic dysregulation following major injury

.

Ann Transl Med

.

2020

. ;

8

(

23

):

1576

-

1589

.

10.

Darlington

DN

,

Gonzales

MD

,

Craig

T

,

Dubick

MA

,

Cap

AP

,

Schwacha

MG

.

Trauma-induced coagulopathy is associated with a complex inflammatory response in the rat

.

Shock

.

2015

. ;

44

(

Suppl 1

):

129

-

137

.

11.

Okeny

PK

,

Ongom

P

,

Kituuka

O

.

Serum interleukin-6 level as an early marker of injury severity in trauma patients in an urban low-income setting: a cross-sectional study

.

BMC Emerg Med

.

2015

. ;

15

:

(22):1

-

7

.

12.

Hayakawa

M

.

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype

.

J Intensive Care

.

2017

. ;

5

:

(14):1

-

7

.

13.

Han

CY

,

Pichon

TJ

,

Wang

X

, et al.

Leukocyte activation primes fibrinogen for proteolysis by mitochondrial oxidative stress

.

Redox Biol

.

2022

. ;

51

(

102263

):

1

-

11

.

14.

Lorand

L

.

'Fibrino-peptide'; new aspects of the fibrinogen-fibrin transformation

.

Nature

.

1951

. ;

167

(

4259

):

992

-

993

.

15.

Blombäck

B

,

Hessel

B

,

Hogg

D

,

Therkildsen

L

.

A two-step fibrinogen--fibrin transition in blood coagulation

.

Nature

.

1978

. ;

275

(

5680

):

501

-

505

.

16.

Budzynski

AZ

,

Olexa

SA

,

Pandya

BV

.

Fibrin polymerization sites in fibrinogen and fibrin fragments

.

Ann N Y Acad Sci

.

1983

. ;

408(1)

:

301

-

314

.

17.

Hayakawa

M

.

Dynamics of fibrinogen in acute phases of trauma

.

J Intensive Care

.

2017

. ;

5

(

1

):

3

-

9

.

18.

Lucena

LS

,

Rodrigues

RDR

,

Carmona

MJC

, et al.

Early administration of fibrinogen concentrate in patients with polytrauma with thromboelastometry suggestive of hypofibrinogenemia: a randomized feasibility trial

.

Clinics (Sao Paulo)

.

2021

. ;

76

(

e3168

):

1

-

7

.

19.

Rourke

C

,

Curry

N

,

Khan

S

, et al.

Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes

.

J Thromb Haemost

.

2012

. ;

10

(

7

):

1342

-

1351

.

20.

Shacter

E

,

Williams

JA

,

Lim

M

,

Levine

RL

.

Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay

.

Free Radic Biol Med

.

1994

. ;

17

(

5

):

429

-

437

.

21.

Weigandt

KM

,

White

N

,

Chung

D

, et al.

Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen

.

Biophys J

.

2012

. ;

103

(

11

):

2399

-

2407

.

22.

Burney

PR

,

White

N

,

Pfaendtner

J

.

Structural effects of methionine oxidation on isolated subdomains of human fibrin D and αC regions

.

PLoS One

.

2014

. ;

9

(

1

):

e86981:1-10

.

23.

Martinez

M

,

Weisel

JW

,

Ischiropoulos

H

.

Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots

.

Free Radic Biol Med

.

2013

. ;

65(1)

:

411

-

418

.

24.

White

NJ

,

Wang

Y

,

Fu

X

, et al.

Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury

.

Free Radic Biol Med

.

2016

. ;

96(1)

:

181

-

189

.

25.

Getting

SJ

.

Targeting melanocortin receptors as potential novel therapeutics

.

Pharmacol Ther

.

2006

. ;

111

(

1

):

1

-

15

.

26.

Leone

S

,

Noera

G

,

Bertolini

A

.

Developments and new vistas in the field of melanocortins

.

Biomol Concepts

.

2015

. ;

6

(

5-6

):

361

-

382

.

27.

Wang

W

,

Guo

DY

,

Lin

YJ

,

Tao

YX

.

Melanocortin regulation of inflammation

.

Front Endocrinol (Lausanne)

.

2019

. ;

10

(

683

):

1

-

15

.

28.

Chern

CR

,

Chern

CJ

,

Velíšková

J

,

Velíšek

L

.

AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: head-to-head comparison with ACTH

.

Epilepsy Res

.

2019

. ;

152(1)

:

31

-

34

.

29.

Catania

A

,

Lonati

C

,

Sordi

A

,

Carlin

A

,

Leonardi

P

,

Gatti

S

.

The melanocortin system in control of inflammation

.

ScientificWorldJournal

.

2010

. ;

10(1)

:

1840

-

1853

.

30.

Getting

SJ

,

Allcock

GH

,

Flower

R

,

Perretti

M

.

Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties

.

J Leukoc Biol

.

2001

. ;

69

(

1

):

98

-

104

.

31.

Gatti

S

,

Lonati

C

,

Sordi

A

,

Catania

A

.

Protective effects of melanocortins in systemic host reactions

.

Adv Exp Med Biol

.

2010

. ;

681(1)

:

117

-

125

.

32.

Guarini

S

,

Tagliavini

S

,

Bazzani

C

,

Ferrari

W

,

Bertolini

A

.

Early treatment with ACTH-(1-24) in a rat model of hemorrhagic shock prolongs survival and extends the time-limit for blood reinfusion to be effective

.

Crit Care Med

.

1990

. ;

18

(

8

):

862

-

865

.

33.

Noera

G

,

Lamarra

M

,

Guarini

S

,

Bertolini

A

.

Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24)

.

Lancet

.

2001

. ;

358

(

9280

):

469

-

470

.

34.

Giuliani

D

,

Mioni

C

,

Bazzani

C

, et al.

Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

.

Br J Pharmacol

.

2007

. ;

150

(

5

):

595

-

603

.

35.

Giuliani

D

,

Minutoli

L

,

Ottani

A

, et al.

Melanocortins as potential therapeutic agents in severe hypoxic conditions

.

Front Neuroendocrinol

.

2012

. ;

33

(

2

):

179

-

193

.

36.

Goldman

H

,

Morehead

M

,

Murphy

S

.

Use of adrenocorticotrophic hormone analog to minimize brain injury

.

Ann Emerg Med

.

1993

. ;

22

(

6

):

1035

-

1040

.

37.

Bertolini

A

,

Tacchi

R

,

Vergoni

AV

.

Brain effects of melanocortins

.

Pharmacol Res

.

2009

. ;

59

(

1

):

13

-

47

.

38.

Getting

SJ

,

Riffo-Vasquez

Y

,

Pitchford

S

, et al.

A role for MC3R in modulating lung inflammation

.

Pulm Pharmacol Ther

.

2008

. ;

21

(

6

):

866

-

873

.

39.

Si

J

,

Ge

Y

,

Zhuang

S

,

Wang

LJ

,

Chen

S

,

Gong

R

.

Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms

.

Kidney Int

.

2013

. ;

83

(

4

):

635

-

646

.

40.

Berenson

R MM

,

Wallis

W

,

Dua

R

,

Moore

M

,

Terkeltaub

R

,

Clegg

C

.

A melanocortin fusion peptide (AQB-565) optimized for melanocortin receptor engagement significantly reduces inflammation in an in vivo model of acute gout

.

Arthritis Rheumatol

.

2016

. ;

68

(

S10

):

2941

-

2942

.

41.

Prudovsky

I

,

Kacer

D

,

Zucco

VV

, et al.

Tranexamic acid: beyond antifibrinolysis

.

Transfusion

.

2022

. ;

62

(

Suppl 1

):

S301

-

S312

.

42.

Francis

WR

,

Ireland

RE

,

Spear

AM

, et al.

Flow cytometric analysis of hematopoietic populations in rat bone marrow. impact of trauma and hemorrhagic shock

.

Cytometry A

.

2019

. ;

95

(

11

):

1167

-

1177

.

43.

Lamm

RJ

,

Lim

EB

,

Weigandt

KM

,

Pozzo

LD

,

White

NJ

,

Pun

SH

.

Peptide valency plays an important role in the activity of a synthetic fibrin-crosslinking polymer

.

Biomaterials

.

2017

. ;

132(1)

:

96

-

104

.

44.

Swystun

LL

,

Liaw

PC

.

The role of leukocytes in thrombosis

.

Blood

.

2016

. ;

128

(

6

):

753

-

762

.

45.

Moore

EE

,

Moore

HB

,

Kornblith

LZ

, et al.

Trauma-induced coagulopathy

.

Nat Rev Dis Primers

.

2021

. ;

7

(

30

):

1

-

23

.

46.

Sies

H

,

Berndt

C

,

Jones

DP

.

Oxidative stress

.

Annu Rev Biochem

.

2017

. ;

86(1)

:

715

-

748

.

47.

Yasunari

K

,

Maeda

K

,

Nakamura

M

,

Yoshikawa

J

.

Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein

.

Hypertension

.

2002

. ;

39

(

3

):

777

-

780

.

48.

Shakur

H

,

Roberts

I

,

Bautista

R

, et al.

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

.

Lancet

.

2010

. ;

376

(

9734

):

23

-

32

.

49.

Morrison

JJ

,

Dubose

JJ

,

Rasmussen

TE

,

Midwinter

MJ

.

Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study

.

Arch Surg

.

2012

. ;

147

(

2

):

113

-

119

.

50.

Weichselbaum

N

,

Oberladstätter

D

,

Schlimp

CJ

, et al.

High interleukin-6 plasma concentration upon admission is predictive of massive transfusion in severely injured patients

.

J Clin Med

.

2021

. ;

10

(

11

):

2268

. 1-11.

51.

Doolittle

RF

,

Watt

KW

,

Cottrell

BA

,

Strong

DD

,

Riley

M

.

The amino acid sequence of the alpha-chain of human fibrinogen

.

Nature

.

1979

. ;

280

(

5722

):

464

-

468

.

52.

Marik

PE

,

Khangoora

V

,

Rivera

R

,

Hooper

MH

,

Catravas

J

.

Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study

.

Chest

.

2017

. ;

151

(

6

):

1229

-

1238

.

53.

Kim

WY

,

Jo

EJ

,

Eom

JS

, et al.

Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score-based analysis of a before-after cohort study

.

J Crit Care

.

2018

. ;

47(1)

:

211

-

218

.

54.

Hwang

SY

,

Ryoo

SM

,

Park

JE

, et al.

Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study

.

Intensive Care Med

.

2020

. ;

46

(

11

):

2015

-

2025

.

55.

Fujii

T

,

Luethi

N

,

Young

PJ

, et al.

Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial

.

JAMA

.

2020

. ;

323

(

5

):

423

-

431

.

56.

Moskowitz

A

,

Huang

DT

,

Hou

PC

, et al.

Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial

.

JAMA

.

2020

. ;

324

(

7

):

642

-

650

.

57.

Collier

BR

,

Giladi

A

,

Dossett

LA

,

Dyer

L

,

Fleming

SB

,

Cotton

BA

.

Impact of high-dose antioxidants on outcomes in acutely injured patients

.

JPEN J Parenter Enteral Nutr

.

2008

. ;

32

(

4

):

384

-

388

.

58.

Nathens

AB

,

Neff

MJ

,

Jurkovich

GJ

, et al.

Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients

.

Ann Surg

.

2002

. ;

236

(

6

):

814

-

822

.

59.

Niemi

TT

,

Munsterhjelm

E

,

Pöyhiä

R

,

Hynninen

MS

,

Salmenperä

MT

.

The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm

.

Blood Coagul Fibrinolysis

.

2006

. ;

17

(

1

):

29

-

34

.

60.

Martinez de Lizarrondo

S

,

Gakuba

C

,

Herbig

BA

, et al.

Potent thrombolytic effect of N-acetylcysteine on arterial thrombi

.

Circulation

.

2017

. ;

136

(

7

):

646

-

660

.

61.

Gibson

KR

,

Winterburn

TJ

,

Barrett

F

,

Sharma

S

,

MacRury

SM

,

Megson

IL

.

Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

.

Cardiovasc Diabetol

.

2011

. ;

10

(

43

):

1

-

8

.

62.

Cohen

J

,

Carlet

J

.

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group

.

Crit Care Med

.

1996

. ;

24

(

9

):

1431

-

1440

.

63.

Reinhart

K

,

Menges

T

,

Gardlund

B

, et al.

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES Study

.

Crit Care Med

.

2001

. ;

29

(

4

):

765

-

769

.

64.

Abraham

E

,

Anzueto

A

,

Gutierrez

G

, et al.

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group

.

Lancet

.

1998

. ;

351

(

9107

):

929

-

933

.

65.

Ho-Mahler

N

,

Turner

B

,

Eaddy

M

,

Hanke

ML

,

Nelson

WW

.

Treatment with repository corticotropin injection in patients with rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis/polymyositis

.

Open Access Rheumatol

.

2020

. ;

12(1)

:

21

-

28

.

66.

Kim

ES

,

Garnock-Jones

KP

.

Afamelanotide: a review in erythropoietic protoporphyria

.

Am J Clin Dermatol

.

2016

. ;

17

(

2

):

179

-

185

.

67.

Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration

. 2005. Accessed 23 November 2022. https://www.fda.gov/media/72309/download.

68.

Roquilly

A

,

Mahe

PJ

,

Seguin

P

, et al.

Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study

.

JAMA

.

2011

. ;

305

(

12

):

1201

-

1209

.